keyword
https://read.qxmd.com/read/38506739/redo-tavi-with-the-acurate-neo2-and-prime-xl-for-balloon-expandable-transcatheter-heart-valve-failure
#1
JOURNAL ARTICLE
David Meier, Daire Grant, Chris Frawley, Mariama Akodad, Uri Landes, Arif A Kokhar, Dariusz Dudek, Isaac George, Michael J Rinaldi, Won-Keun Kim, Steven J Yakubov, Paul Sorajja, Giuseppe Tarantini, David A Wood, John G Webb, Stephanie L Sellers, Janarthanan Sathananthan
BACKGROUND: There are limited data regarding treatment for failed balloon-expandable transcatheter heart valves (THVs) in redo-transcatheter aortic valve implantation (TAVI). AIMS: We aimed to assess THV performance, neoskirt height and expansion when performing redo-TAVI with the ACURATE platform inside a SAPIEN 3 (S3) compared to redo-TAVI with an S3 in an S3. METHODS: Redo-TAVI was performed on the bench using each available size of the S3, the ACURATE neo2 (ACn2) and the next-generation ACURATE Prime XL (AC XL) implanted at 2 different depths within 20 mm/23 mm/26 mm/29 mm S3s serving as the "failed" index THV...
March 18, 2024: EuroIntervention
https://read.qxmd.com/read/38423848/safety-and-effectiveness-of-the-novel-myval-octacor-transcatheter-heart-valve-in-severe-symptomatic-aortic-valve-stenosis-a-real-world-indian-experience-the-octacor-india-study
#2
JOURNAL ARTICLE
John Jose, Asishkumar Mandalay, Manjunath N Cholenahally, Ravindranath S Khandenahally, Srinivas C Budnur, Maulik Parekh, Ravinder S Rao, Ashok Seth, Praveen Chandra, Rajneesh Kapoor, Praveer Agarwal, Atul Mathur, Vijay Kumar, Sadananda S Kanchanahalli, Ajith S Mullasari, Vijayakumar Subban, Uday B Khanolkar, Sanjay Mehrotra, Manik Chopra, Rajendra K Jain, Haresh Mehta, Rahul Gupta, Viveka Kumar, Bagirath Raghuraman, Naman Shastri, Hesham Elzomor, Osama Soliman, Sengottuvelu Gunasekaran
PURPOSE: To evaluate the safety and effectiveness of the novel, next-generation Myval Octacor - Transcatheter Heart Valve (THV) in patients with severe, symptomatic, native aortic stenosis (AS). METHODS: This multicenter, real-world observational registry included 123 patients with severe symptomatic AS, across 16 Indian centers who underwent treatment with the novel Myval Octacor THV. Study endpoints included all-cause mortality, all stroke, acute kidney injury (AKI), major vascular complications, moderate or severe paravalvular leakage (PVL) and new permanent pacemaker implantation (PPI) until 30 days follow-up...
January 28, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38236417/low-flow-in-aortic-valve-stenosis-patients-with-reduced-ejection-fraction-does-not-depend-on-left-ventricular-function
#3
JOURNAL ARTICLE
Svante Gersch, Torben Lange, Bo Eric Beuthner, Manar Elkenani, Niels Paul, Moritz Schnelle, Elisabeth Zeisberg, Miriam Puls, Gerd Hasenfuß, Andreas Schuster, Karl Toischer
BACKGROUND: Patients with severe aortic stenosis (AS) and reduced left ventricular ejection fraction (LVEF) can be distinguished into high- (HG) and low-gradient (LG) subgroups. However, less is known about their characteristics and underlying (pathophysiological) hemodynamic mechanisms. METHODS: 98 AS patients with reduced LVEF were included. Subgroup characteristics were analyzed by a multimodal approach using clinical and histological data, next-generation sequencing (NGS) and applying echocardiography as well as cardiovascular magnetic resonance (CMR) imaging...
January 18, 2024: Clinical Research in Cardiology: Official Journal of the German Cardiac Society
https://read.qxmd.com/read/38201247/understanding-bartonella-associated-infective-endocarditis-examining-heart-valve-and-vegetation-appearance-and-the-role-of-neutrophilic-leukocytes
#4
JOURNAL ARTICLE
Kristians Meidrops, Valerija Groma, Niks Ricards Goldins, Lauma Apine, Sandra Skuja, Simons Svirskis, Dita Gudra, Davids Fridmanis, Peteris Stradins
The endocardium and cardiac valves undergo severe impact during infective endocarditis (IE), and the formation of vegetation places IE patients at a heightened risk of embolic complications and mortality. The relevant literature indicates that 50% of IE cases exhibit structurally normal cardiac valves, with no preceding history of heart valve disease. Gram-positive cocci emerge as the predominant causative microorganisms in IE, while Gram-negative Bartonella spp., persisting in the endothelium, follow pathogenic pathways distinct from those of typical IE-causing agents...
December 25, 2023: Cells
https://read.qxmd.com/read/38106454/exploratory-simulation-of-thrombosis-in-a-temporary-lvad-catheter-pump-within-a-virtual-in-vivo-left-heart-environment
#5
Greg W Burgreen, Mansur Zhussupbekov, Rodrigo Méndez Rojano, James F Antaki
Percutaneous catheter pumps are intraventricular temporary mechanical circulatory support (MCS) devices that are positioned across the aortic valve into the left ventricle (LV) and provide continuous antegrade blood flow from the LV into the ascending aorta (AA). MCS devices are most often computationally evaluated as isolated devices subject to idealized steady-state blood flow conditions. In clinical practice, MCS devices operate connected to or within diseased pulsatile native hearts and are often complicated by hemocompatibility related adverse events such as stroke, bleeding, and thrombosis...
December 8, 2023: ArXiv
https://read.qxmd.com/read/38099239/compact-design-and-task-space-control-of-a-robotic-transcatheter-delivery-system-for-mitral-valve-implant
#6
JOURNAL ARTICLE
Ronghuai Qi, Namrata U Nayar, Jaydev P Desai
Mitral regurgitation (MR) is one of the most common valvular abnormalities, and the gold-standard for treatment is surgical mitral valve repair/replacement. Most patients with severe MR are over the age of 75, which makes open-heart surgery challenging. Thus, minimally invasive surgeries using transcatheter approaches are gaining popularity. This paper proposes the next generation of a robotic transcatheter delivery system for the mitral valve implant that focuses on the design of the actuation system, modeling, and task space control...
November 2023: IEEE transactions on medical robotics and bionics
https://read.qxmd.com/read/38068501/the-potential-of-intertwining-gene-diagnostics-and-surgery-for-mitral-valve-prolapse
#7
REVIEW
Jasper Iske, Maximilian J Roesel, Nikola Cesarovic, Leonard Pitts, Annabel Steiner, Leonard Knoedler, Timo Z Nazari-Shafti, Serdar Akansel, Stephan Jacobs, Volkmar Falk, Joerg Kempfert, Markus Kofler
Mitral valve prolapse (MVP) is common among heart valve disease patients, causing severe mitral regurgitation (MR). Although complications such as cardiac arrhythmias and sudden cardiac death are rare, the high prevalence of the condition leads to a significant number of such events. Through next-generation gene sequencing approaches, predisposing genetic components have been shown to play a crucial role in the development of MVP. After the discovery of the X-linked inheritance of filamin A, autosomal inherited genes were identified...
November 30, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37810997/engineered-extracellular-vesicle-based-therapies-for-valvular-heart-disease
#8
JOURNAL ARTICLE
Ana I Salazar-Puerta, Mia Kordowski, Tatiana Z Cuellar-Gaviria, Maria A Rincon-Benavides, Jad Hussein, Dorma Flemister, Gabriel Mayoral-Andrade, Grant Barringer, Elizabeth Guilfoyle, Britani N Blackstone, Binbin Deng, Diana Zepeda-Orozco, David W McComb, Heather Powell, Lakshmi P Dasi, Daniel Gallego-Perez, Natalia Higuita-Castro
INTRODUCTION: Valvular heart disease represents a significant burden to the healthcare system, with approximately 5 million cases diagnosed annually in the US. Among these cases, calcific aortic stenosis (CAS) stands out as the most prevalent form of valvular heart disease in the aging population.  CAS is characterized by the progressive calcification of the aortic valve leaflets, leading to valve stiffening. While aortic valve replacement is the standard of care for CAS patients, the long-term durability of prosthetic devices is poor, calling for innovative strategies to halt  or reverse disease progression...
August 2023: Cellular and Molecular Bioengineering
https://read.qxmd.com/read/37770978/triple-repeated-fetal-congenital-heart-disease-linked-to-pld1-mutation-a-case-report
#9
JOURNAL ARTICLE
Yuki Masuda, Yoko Nagayasu, Hikaru Murakami, Ruri Nishie, Natsuko Morita, Sosuke Hashida, Atsushi Daimon, Misa Nunode, Hiroshi Maruoka, Masae Yoo, Takumi Sano, Yutaka Odanaka, Satoe Fujiwara, Daisuke Fujita, Nobuhiko Okamoto, Masahide Ohmichi
BACKGROUND: Congenital heart disease occurs in approximately 1 in 100 cases. Although sibling occurrence is high (3-9%), the causative genes for this disease are still being elucidated. PLD1 (Phospholipase D1) is a recently discovered gene; however, few case reports have been published on it. In this report, we describe a case of triplicate fetal congenital heart disease that was diagnosed as a PDL1 mutation. Our objective is to explore the clinical manifestations of PLD1 mutations in this particular case...
September 29, 2023: Journal of Medical Case Reports
https://read.qxmd.com/read/37692179/an-evasive-case-of-gonococcal-endocarditis
#10
William N Butler, Connor Stephenson, Benjamin D Young, Pranav Shah
Neisseria gonorrhoeae is one of the most common sexually transmitted infections in the United States, and disseminated infection can lead to a variety of complications. This includes the less common, but potentially life-threatening complication of gonococcal endocarditis. The authors report a case of a formerly incarcerated middle-aged man with a three-day history of dyspnea on exertion, fever, headache, and productive cough with green sputum. He endorsed a several-week history of an untreated right molar infection but denied any history of genitourinary symptoms...
September 2023: Curēus
https://read.qxmd.com/read/37476058/pediatric-pulmonary-valve-replacements-clinical-challenges-and-emerging-technologies
#11
REVIEW
Matthew Crago, David S Winlaw, Syamak Farajikhah, Fariba Dehghani, Sina Naficy
Congenital heart diseases (CHDs) frequently impact the right ventricular outflow tract, resulting in a significant incidence of pulmonary valve replacement in the pediatric population. While contemporary pediatric pulmonary valve replacements (PPVRs) allow satisfactory patient survival, their biocompatibility and durability remain suboptimal and repeat operations are commonplace, especially for very young patients. This places enormous physical, financial, and psychological burdens on patients and their parents, highlighting an urgent clinical need for better PPVRs...
July 2023: Bioengineering & Translational Medicine
https://read.qxmd.com/read/37436146/16s-rrna-gene-pcr-sequencing-of-heart-valves-for-diagnosis-of-infective-endocarditis-in-routine-clinical-practice
#12
JOURNAL ARTICLE
Hyo-Lim Hong, Laure Flurin, Kerryl E Greenwood-Quaintance, Matthew J Wolf, Bobbi S Pritt, Andrew P Norgan, Robin Patel
Sequencing is increasingly used for infective endocarditis (IE) diagnosis. Here, the performance of 16S rRNA gene PCR/sequencing of heart valves utilized in routine clinical practice was compared with conventional IE diagnostics. Subjects whose heart valves were sent to the clinical microbiology laboratory for 16S rRNA gene PCR/sequencing from August 2020 through February 2022 were studied. A PCR assay targeting V1 to V3 regions of the 16S rRNA gene was performed, followed by Sanger and/or next-generation sequencing (NGS) (using an Illumina MiSeq), or reported as negative, depending on an algorithm that included the PCR cycle threshold value...
August 23, 2023: Journal of Clinical Microbiology
https://read.qxmd.com/read/37401984/microbiota-present-in-combined-endodontic-periodontal-diseases-and-its-risks-for-endocarditis
#13
JOURNAL ARTICLE
Brenda P F A Gomes, Vanessa B Berber, Vito M Chiarelli-Neto, Emelly Aveiro, Rafaela C Chapola, Maicon R Z Passini, Erica M Lopes, Tsute Chen, Bruce J Paster
INTRODUCTION: Infective endocarditis (IE) is an inflammatory disease usually caused by bacteria that enter the bloodstream and establish infections in the inner linings or valves of the heart, including blood vessels. Despite the availability of modern antimicrobial and surgical treatments, IE continues to cause substantial morbidity and mortality. Oral microbiota is considered one of the most significant risk factors for IE. The objective of this study was to evaluate the microbiota present in root canal (RC) and periodontal pocket (PP) clinical samples in cases with combined endo-periodontal lesions (EPL) to detect species related to IE using NGS...
July 4, 2023: Clinical Oral Investigations
https://read.qxmd.com/read/37274165/biomechanical-performance-of-the-bicaval-transcatheter-system-for-the-treatment-of-severe-tricuspid-regurgitation
#14
JOURNAL ARTICLE
Fabrizio Crascì, Stefano Cannata, Giovanni Gentile, Caterina Gandolfo, Salvatore Pasta
Introduction: Tricuspid regurgitation (TR) is a relatively common valvular disease, which can result from structural abnormalities of any anatomic part of the tricuspid valve. Severe TR is linked to congestive heart failure and hemodynamic impairment, resulting in high mortality when repaired by elective surgery. This study was undertaken to quantify the structural and hemodynamic performance of the novel Transcatheter Bicaval Valves System (TricValve) percutaneously implanted in the superior vena cava (SVC) and inferior vena cava (IVC) of two patients with severe TR and venous congestion...
2023: Frontiers in Bioengineering and Biotechnology
https://read.qxmd.com/read/37241171/infective-endocarditis-during-pregnancy-keep-it-safe-and-simple
#15
REVIEW
Viviana Aursulesei Onofrei, Cristina Andreea Adam, Dragos Traian Marius Marcu, Radu Crisan Dabija, Alexandr Ceasovschih, Mihai Constantin, Elena-Daniela Grigorescu, Antoneta Dacia Petroaie, Florin Mitu
The diagnosis of infective endocarditis (IE) during pregnancy is accompanied by a poor prognosis for both mother and fetus in the absence of prompt management by multidisciplinary teams. We searched the electronic databases of PubMed, MEDLINE and EMBASE for clinical studies addressing the management of infective endocarditis during pregnancy, with the aim of realizing a literature review ranging from risk factors to diagnostic investigations to optimal therapeutic management for mother and fetus alike. The presence of previous cardiovascular pathologies such as rheumatic heart disease, congenital heart disease, prosthetic valves, hemodialysis, intravenous catheters or immunosuppression are the main risk factors predisposing patients to IE during pregnancy...
May 12, 2023: Medicina
https://read.qxmd.com/read/37214350/towards-the-design-and-development-of-a-robotic-transcatheter-delivery-system-for-mitral-valve-implant
#16
JOURNAL ARTICLE
Namrata U Nayar, Ronghuai Qi, Jaydev P Desai
Minimally-invasive surgeries using transcatheter approaches and sophisticated imaging modalities are gaining popularity to treat mitral regurgitation (MR). This paper proposes the next generation of a robotic catheter to deliver an implant onto the mitral valve (MV) through a transseptal approach. The proposed robot has an outer diameter (OD) of 5.7 mm, a rigid distal end length of 20 mm, a prismatic tube that can be advanced by 50-60 mm, and a bending joint that can easily bend 120° to reach the valve opening...
November 2022: IEEE transactions on medical robotics and bionics
https://read.qxmd.com/read/37213874/what-s-new-with-tavr-an-update-on-device-technology
#17
REVIEW
Syed Zaid, Marvin D Atkins, Neal S Kleiman, Michael J Reardon, Gilbert H L Tang
Over the last 20 years, transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic stenosis and has become the standard of care across the entire spectrum of surgical risk. Expansion of TAVR in treating younger, lower-risk patients with longer life expectancies, and treating earlier in the disease process, has seen a continuous evolution in device technology, with several next-generation transcatheter heart valves developed to minimize procedural complications and improve patient outcomes...
2023: Methodist DeBakey Cardiovascular Journal
https://read.qxmd.com/read/37158846/endocarditis-due-to-aggregatibacter-segnis-a-rare-case-report
#18
JOURNAL ARTICLE
Xiaoxiao Guo, Xinyun Zhang, Yanli Qin, Hong Liu, Xinyu Wang
BACKGROUND: As a member of the HACEK group, Aggregatibacter segnis (A. segnis) is a fastidious Gram-negative coccobacillus that resides in the human oropharyngeal flora. Infective endocarditis caused by A. segnis is rarely reported. CASE PRESENTATION: A 31-year-old male was admitted to our hospital for a 3-month history of intermittent high fever, chills, and chest distress. On presentation, he was febrile and tachycardic but otherwise with stable vital signs. Physical examination revealed systolic murmurs in the aortic and mitral valve areas...
May 8, 2023: BMC Infectious Diseases
https://read.qxmd.com/read/37077226/free-aldehyde-neutralized-and-oligohyaluronan-loaded-bovine-pericardium-with-improved-anti-calcification-and-endothelialization-for-bioprosthetic-heart-valves
#19
JOURNAL ARTICLE
Yuhong Liu, Chunyang Chen, Ting Lu, Sixi Liu, Zhongshi Wu, Zhenjie Tang
The number of patients with valvular heart disease is increasing yearly, and valve replacement is the most effective treatment, during which bioprosthetic heart valves (BHVs) are the most widely used. Commercial BHVs are mainly prepared with glutaraldehyde (Glut) cross-linked bovine pericardial or porcine aortic valves, but the residual free aldehyde groups in these tissues can cause calcification and cytotoxicity. Moreover, insufficient glycosaminoglycans (GAGs) in tissues can further reduce biocompatibility and durability...
2023: Frontiers in Bioengineering and Biotechnology
https://read.qxmd.com/read/37059087/reducing-retraction-in-engineered-tissues-through-design-of-sequential-growth-factor-treatment
#20
JOURNAL ARTICLE
Ying Lei, Rozanne Mungai, Juanyong Li, Kristen Billiar
Heart valve disease is associated with high morbidity and mortality worldwide resulting in hundreds of thousands of heart valve replacements each year. Tissue engineered heart valves (TEHVs) have the potential to overcome the major limitations of traditional replacement valves; however, leaflet retraction has led to the failure of TEHVs in preclinical studies. Sequentially varying growth factors over time has been utilized to promote maturation of engineered tissues and may be effective in reducing tissue retraction, yet it is difficult to predict the effects of such treatments due to complex between the cells and the extracellular matrix (ECM), biochemical environment, and mechanical stimuli...
April 14, 2023: Biofabrication
keyword
keyword
14850
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.